@alexabliss031
Profile
Registered: 5 years, 7 months ago
Lenalid has antineoplastic, antiangiogenic, pro-erythropoietic and immunomodulating properties. Lenalidomide inhibits the proliferation of certain malignant hematopoietic cells (including multiple myeloma (MM) cells and hematopoietic tumor cells that have cytogenetic defects of chromosome 5), strengthens T-cell and cell-mediated natural killer (EC) immunity, increases the number of EC T cells, inhibits angiogenesis, blocking the migration and adhesion of endothelial cells and the formation of microvessels, increases the production of fetal hemoglobin CD 34+ hematopoietic stem cells, and inhibits the production of pro-inflammatory cytokines (for example, tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6)) by monocytes. Lenalidomide was studied in 2 studies of phase III for the first time diagnosed with MM and 2 studies of phase III for relapses of refractory MM. lenalid 5 mg lenalid 25 mg lenalid 15 mg harvoni cost
Forums
Last Activity: 5 years, 7 months ago
Topics Started: 0
Replies Created: 0
Forum Role: Blocked